iRhythm Holdings
iRhythm Technologies Inc is an American digital healthcare company manufacturing wearable cardiac monitoring devices and AI-driven diagnostic platforms for cardiac arrhythmia detection. The company produces the Zio patch wearable biosensor and operates AI analytics platforms that record continuous electrocardiogram (ECG) data to detect atrial fibrillation and other cardiac conditions. Principal revenues derive from clinical diagnostic testing fees and health insurance reimbursements collected per completed Zio diagnostic report from healthcare payors. Core end markets encompass clinical cardiology practices, hospital health systems, electrophysiologists, and cardiac patients across the United States, the UK, and Europe. iRhythm Technologies holds a market-leading position in North America for ambulatory continuous cardiac monitoring and AI-driven ECG diagnostic processing. The corporation is headquartered in San Francisco, California, and its common stock trades on the Nasdaq Global Select Market.
5 of the funds FundTelligence covers report a position in iRhythm Holdings.
- Legal name
- iRhythm Holdings Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 5
Funds holding iRhythm Holdings
- HealthInvest Small & Mid Cap Healthcare — HealthInvest · 2.4 % (partially disclosed portfolio, September 2026)
- Schroder ISF US Smaller Companies Impact — Schroders · 1.64 % (full portfolio disclosed, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.05 % (full portfolio disclosed, October 2026)
- SEB Global Sustainable Companies Fund — SEB · 0.04 % (full portfolio disclosed, June 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.03 % (partially disclosed portfolio, June 2026)